<!DOCTYPE html><html><head><title> Pacifica Code Section 58-37-S3.6 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b><i>
                      Effective 7/1/2019</i></b>
<br>
<b>58-37-3.6.&nbsp;
          </b><b>Exemption for possession or distribution of a cannabinoid product or expanded cannabinoid product pursuant to an approved study.</b>
<br>
<a id="58-37-3.6(1)" name="58-37-3.6(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
As used in this section:
<a id="58-37-3.6(1)(a)" name="58-37-3.6(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
"Cannabinoid product" means a product intended for human ingestion that:<a id="58-37-3.6(1)(a)(i)" name="58-37-3.6(1)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
contains an extract or concentrate that is obtained from cannabis;</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(a)(ii)" name="58-37-3.6(1)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
is prepared in a medicinal dosage form; and</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(a)(iii)" name="58-37-3.6(1)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
contains at least 10 units of cannabidiol for every one unit of tetrahydrocannabinol.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(b)" name="58-37-3.6(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
"Cannabis" means any part of the plant cannabis sativa, whether growing or not.</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(c)" name="58-37-3.6(1)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
"Drug paraphernalia" means the same as that term is defined in Section <a href="../../Title58/Chapter37A/58-37a-S3.html?v=C58-37a-S3_1800010118000101">58-37a-3</a>.</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(d)" name="58-37-3.6(1)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
"Expanded cannabinoid product" means a product intended for human ingestion that:<a id="58-37-3.6(1)(d)(i)" name="58-37-3.6(1)(d)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
contains an extract or concentrate that is obtained from cannabis;</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(d)(ii)" name="58-37-3.6(1)(d)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
is prepared in a medicinal dosage form; and</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(d)(iii)" name="58-37-3.6(1)(d)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
contains less than 10 units of cannabidiol for every one unit of tetrahydrocannabinol.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(e)" name="58-37-3.6(1)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
"Medicinal dosage form" means:<a id="58-37-3.6(1)(e)(i)" name="58-37-3.6(1)(e)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
a tablet;</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(e)(ii)" name="58-37-3.6(1)(e)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
a capsule;</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(e)(iii)" name="58-37-3.6(1)(e)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
a concentrated oil;</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(e)(iv)" name="58-37-3.6(1)(e)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
a liquid suspension;</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(e)(v)" name="58-37-3.6(1)(e)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
a transdermal preparation; or</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(e)(vi)" name="58-37-3.6(1)(e)(vi)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vi)</td><td style="width:99%">
a sublingual preparation.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-3.6(1)(f)" name="58-37-3.6(1)(f)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(f)</td><td style="width:99%">
"Tetrahydrocannabinol" means a substance derived from cannabis that meets the description in Subsection <a href="../../Title58/Chapter37/58-37-S4.html?v=C58-37-S4_2019051420190514#58-37-4(2)(a)(iii)(AA)">58-37-4(2)(a)(iii)(AA)</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-3.6(2)" name="58-37-3.6(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
Notwithstanding any other provision of this chapter an individual who possesses or distributes a cannabinoid product or an expanded cannabinoid product is not subject to the penalties described in this title for the possession or distribution of marijuana or tetrahydrocannabinol to the extent that the individual's possession or distribution of the cannabinoid product or expanded cannabinoid product complies with <a href="../../Title26/Chapter61/26-61.html?v=C26-61_2017032520170325">Title 26, Chapter 61, Cannabinoid Research Act</a>.</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=1&amp;sess=2018S3">1</a>, 2018 Special Session 3<br>
</body></html>